---
$id: https://graph.org.ai/products/commodity/51141582
$type: Product
source: UNSPSC
code: "51141582"
title: "Tiagabine"
class: "51141500"
classTitle: "Anticonvulsants"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tiagabine

**UNSPSC Code**: 51141582
**Class**: [Anticonvulsants](Anticonvulsants.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticonvulsant agent with the molecular formula C20H25NO2S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z80I64HMNP, chemically known as 3-piperidinecarboxylic acid, 1-(4,4-bis(3-methyl-2-thienyl)-3-butenyl)-, (r)- but generally known as tiagabine, which bears US NIH Compound Identifier 60648. European Medicines Agency schedules Tiagabine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11000MIG. The term TIAGABINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). World Health Organization schedules tiagabine in its Anatomical Therapeutic Chemical (ATC) Classification. TIAGABINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tiagabine under HS 29349990 and SITC 51579. As of Q4 2014, TIAGABINE remains the US FDA Preferred Term for this commodity. Tiagabine bears US NLM identifiers UMLS ID C0068897 and NCI Concept Code C66602. SMILES: S1C(/C(=C/CCN2CC(CCC2)C(=O)O)C2SCCC2C)C(CC1)C.

